Cambridge, MA, United States of America

Serge Roux

This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge Roux. Retrieved from https://idiyas.com/inventor/serge-roux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Serge Roux

Introduction

Serge Roux is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly with his innovative designs in medical devices. With a total of 2 patents to his name, Roux continues to push the boundaries of medical technology.

Latest Patents

One of his latest inventions is a medicine injector, which aims to improve the delivery of medications to patients. This device showcases his commitment to enhancing patient care through innovative solutions.

Career Highlights

Roux is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with some of the brightest minds in the industry, furthering his impact on medical technology.

Collaborations

Some of his notable coworkers include Nicholas Charles Stones and Martin James Dinnage. Their collective expertise contributes to the innovative environment at Novartis AG.

Conclusion

Serge Roux's contributions to medical technology through his patents and collaborations highlight his dedication to improving healthcare solutions. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…